La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Dyskinesia, Drug-Induced (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dyskinesia, Drug-Induced (history) < Dyskinesia, Drug-Induced (metabolism) < Dyskinesia, Drug-Induced (pathology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000095 (2000) F. Calon [Canada] ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
000203 (2002) Frédéric Calon [Canada] ; Sam Birdi ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloIncrease of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
000284 (2003) Frédéric Calon [Canada] ; Marc Morissette ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloChanges of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
000380 (2003) Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloLevodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
000408 (2004) Abdallah Hadj Tahar [Canada] ; Laurent Grégoire ; Aurélie Darré ; Nancy Bélanger ; Leonard Meltzer ; Paul J. BédardEffect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
000449 (2004) Raúl De La Fuente-Fernández [Canada] ; Vesna Sossi ; Zhigao Huang ; Sarah Furtado ; Jian-Qiang Lu ; Donald B. Calne ; Thomas J. Ruth ; A Jon StoesslLevodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
000484 (2005) J M Brotchie [Canada] ; J. Lee ; K. VenderovaLevodopa-induced dyskinesia in Parkinson's disease.
000552 (2005) Jonathan M. Brotchie [Canada]Nondopaminergic mechanisms in levodopa-induced dyskinesia.
000610 (2006) Carl Julien [Canada] ; Line Berthiaume ; Abdallah Hadj-Tahar ; Ali H. Rajput ; Paul J. Bédard ; Thérèse Di Paolo ; Pierre Julien ; Frédéric CalonPostmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
000670 (2006) Pershia Samadi [Canada] ; Paul J. Bédard ; Claude RouillardOpioids and motor complications in Parkinson's disease.
000826 (2008) Stephen J. Kish [Canada] ; Junchao Tong ; Oleh Hornykiewicz ; Ali Rajput ; Li-Jan Chang ; Mark Guttman ; Yoshiaki FurukawaPreferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
000985 (1991) F B Jolicoeur [Canada] ; R. Rivest ; A. DrumhellerHypokinesia, rigidity, and tremor induced by hypothalamic 6-OHDA lesions in the rat.
000F38 (2011) Philippe Huot [Canada] ; Jonathan M. Brotchie5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms.
000F57 (2011) Jonathan Brotchie [Canada] ; Peter JennerNew approaches to therapy.
000F94 (2012) Laure Chagniel [Canada] ; Christine Robitaille ; Manon Lebel ; Michel CyrStriatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.
001221 (2013) Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di PaoloMPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.
001357 (2013) Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. BrotchieThe pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.
001527 (2013) Susan H. Fox [Canada]Non-dopaminergic treatments for motor control in Parkinson's disease.
001542 (2013) Golnasim Riahi ; Marc Morissette ; Pershia Samadi ; Martin Parent ; Thérèse Di PaoloBasal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
001B57 (2015) Vincent A. Jourdain ; Nicolas Morin ; Laurent Grégoire ; Marc Morissette ; Thérèse Di PaoloChanges in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
001C73 (2015) Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dyskinesia, Drug-Induced (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dyskinesia, Drug-Induced (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dyskinesia, Drug-Induced (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022